<DOC>
	<DOC>NCT01117571</DOC>
	<brief_summary>The study objective is to evaluate the safety and performance of the ConforMIS iUni® Unicompartmental Knee Resurfacing Device in patients with single compartment osteoarthritis. The iUni is a patient-specific unicompartmental resurfacing device designed from the patient's unique anatomy using proprietary software which interprets data from the patient's CT scan. The patient matched implant design is then coupled with unique patient-matched disposable instrumentation designed using the same CT data and software.</brief_summary>
	<brief_title>Multi-Center Study to Evaluate the ConforMIS iUni Knee Implant</brief_title>
	<detailed_description>See eligibility criteria</detailed_description>
	<mesh_term>Osteoarthritis</mesh_term>
	<criteria>1. Clinical condition included in the approved Indications For Use 2. Unicompartmental osteoarthritis of the medial or lateral tibiofemoral compartment 3. Willingness to participate in the clinical study, to give informed consent and to attend all followup visits 4. &gt; 18 years of age 1. Simultaneous bilateral procedure required 2. BMI &gt; 35 3. Treatment for cancer within the past 5 years, with the exception of skin cancer 4. Poorly controlled diabetes 5. Neuromuscular conditions which prevent patient from participating in study activities 6. Active local or systemic infection 7. Immunocompromised 8. Fibromyalgia or other general body pain related condition 9. Advanced tricompartmental osteoarthritis 10. Symptomatic patellofemoral disease 11. Rheumatoid arthritis or other forms of inflammatory joint disease 12. Loss of bone or musculature, osteoporosis, osteonecrosis, neuromuscular or vascular compromise in the area of the joint to be operated to an extent that the procedure is unjustified 13. Advanced loss of osteochondral structure on the affected femoral condyle 14. Compromised ACL, PCL or collateral ligament 15. Severe (&gt;15º) fixed valgus or varus deformity 16. Extension deficit &gt; 15 º 17. Prior history of failed implant surgery of the joint to be treated 18. Unwilling or unable to comply with study requirements 19. Participation in another clinical study which would confound results</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>June 2015</verification_date>
	<keyword>knee</keyword>
	<keyword>osteoarthritis</keyword>
	<keyword>unicompartmental</keyword>
	<keyword>arthroplasty</keyword>
</DOC>